Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial

Gatta‐Cherifi, Blandine; Mohammedi, Kamel; Cariou, Tanguy; Poitou, Christine; Touraine, Philippe; Raverot, Gérald; Brue, Thierry; Chanson, Philippe; Illouz, F.; Grunenwald, Solange; Chabre, Olivier; Sonnet, E.; Cuny, Thomas; Bertherat, Jérôme; Czernichow, Sébastien; Frison, Éric; Tabarin, Antoine

doi:10.1093/ejendo/lvae024

Public

Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial

Published in European Journal of Endocrinology • Mar 6, 2024

Authors:

Blandine Gatta‐Cherifi

Kamel Mohammedi

Tanguy Cariou

Abstract

IMPORTANCE: A major issue in the management of craniopharyngioma-related obesity (CRO) is the ineffectiveness of the current therapeutic approaches. OBJECTIVE: To study the efficacy of glucagon-like peptide-1 analogs compared with placebo in adults with obesity CRO. DESIGN: A double-blind multicente...

Subject

Exenatide

Placebo

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!